Select a Size
About This Item
grade
Molecular Biology
Quality Level
assay
≥98% (HPLC), ≥99% (titration)
form
powder
reaction suitability
reagent type: reductant
mp
41-44 °C (lit.)
solubility
H2O: 50 mg/mL
cation traces
heavy metals (as Pb): ≤5 ppm
suitability
suitable for molecular biology
application(s)
advanced drug delivery
foreign activity
DNase, RNase, protease, none detected
storage temp.
2-8°C
SMILES string
O[C@H](CS)[C@H](O)CS
InChI
1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m1/s1
InChI key
VHJLVAABSRFDPM-QWWZWVQMSA-N
General description
Application
It has been used:
- as a component for protein extraction in western blot analysis
- to prepare sample lysis buffer for quantitative mass spectroscopy
- as a kinase buffer component for enzyme-linked immunosorbent assay (ELISA)
Biochem/physiol Actions
Features and Benefits
- Suitable for molecular biology
- RNase, DNase, Exonuclease, and Protease-free
- High purity (HPLC ≥98%)
- No heavy metal ≤5ppm
Other Notes
Still not finding the right product?
Explore all of our products under DL-Dithiothreitol
signalword
Danger
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1A
Storage Class
8A - Combustible corrosive hazardous materials
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Protocols
Follow this DDT reduction protocol to reduce disulfide bonds in thiol-modified oligonucleotides.
Related Content
Tools for plasmid preparation, in vitro transcription, mRNA purification, and LNP formulation in mRNA-based vaccine and therapeutic development.
Werkzeuge für die Plasmidpräparation, in vitro Transkription, mRNA-Reinigung und LNP-Formulierung in der mRNA-basierten Impfstoff- und Therapieentwicklung.
Outils pour la préparation des plasmides, la transcription in vitro, la purification de l'ARNm et la formulation des LNP dans le cadre du développement de vaccins et de thérapies à base d'ARNm.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D9779-25G | 04061835521821 |
| D9779-50G | 04061835544301 |
| D9779-5G | 04061835544318 |
| D9779-10G | 04061835506286 |
| D9779-1G | 04061835544295 |
| D9779-250MG | 04061835512461 |

